IHE Holdings Information

IHE is an equity ETF with a total of 60 individual holdings. The top holdings are Eli Lilly and Company stock at 23.25%, Johnson & Johnson at 21.94%, Merck & Co. at 4.88%, Zoetis at 4.86%, and Bristol-Myers Squibb Company at 4.60%.

Total Holdings

Top 10 Percentage

77.88%

Asset Class

Equity

ETF Category

Health

Assets

865.20M

PE Ratio

22.79

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	23.25%	203,324
2	JNJ	Johnson & Johnson	21.94%	978,173
3	MRK	Merck & Co., Inc.	4.88%	413,905
4	ZTS	Zoetis Inc.	4.86%	342,221
5	BMY	Bristol-Myers Squibb Company	4.60%	789,027
6	PFE	Pfizer Inc.	4.33%	1,567,348
7	RPRX	Royalty Pharma plc	4.08%	937,223
8	VTRS	Viatris Inc.	3.90%	2,871,094
9	ELAN	Elanco Animal Health Incorporated	3.13%	1,238,568
10	JAZZ	Jazz Pharmaceuticals plc	2.90%	151,472
11	AXSM	Axsome Therapeutics, Inc.	1.99%	105,553
12	CRNX	Crinetics Pharmaceuticals, Inc.	1.25%	236,542
13	INDV	Indivior PLC	1.24%	311,227
14	LGND	Ligand Pharmaceuticals Incorporated	1.03%	49,061
15	TERN	Terns Pharmaceuticals, Inc.	0.92%	214,689
16	CORT	Corcept Therapeutics Incorporated	0.90%	233,359
17	TARS	Tarsus Pharmaceuticals, Inc.	0.85%	97,357
18	PBH	Prestige Consumer Healthcare Inc.	0.82%	119,856
19	SUPN	Supernus Pharmaceuticals, Inc.	0.78%	142,938
20	LQDA	Liquidia Corporation	0.60%	171,310
21	WVE	Wave Life Sciences Ltd.	0.59%	360,314
22	AMRX	Amneal Pharmaceuticals, Inc.	0.59%	422,877
23	AVDL	Avadel Pharmaceuticals plc	0.57%	243,439
24	NUVB	Nuvation Bio Inc.	0.56%	598,225
25	OCUL	Ocular Therapeutix, Inc.	0.54%	424,863

Showing 25 of 60 holdings

Subscribe to see the full list

Activate Now

As of Jan 2, 2026